I know we’re still digesting the latest sales figures but, looking ahead, Daybue sales only need to increase to US$89.5 million this quarter (a QoQ increase of ~5.8%) for NEU to earn the US$50 million milestone payment.
Call me an optimist, but I remain hopeful that this milestone will be achieved in Q3 and shouted to the four corners of the globe. Speaking of which, last year’s Q3 earnings were announced by Acadia after market on 2 November (3 November In Australia).
As an aside, has anyone else been watching the games with the indicative price today whilst we are in a TH? It has settled down in the last hour but I can never make heads or tails of it.
Anyway, good luck all for a positive Angelman’s result, whenever it drops, and most especially for the patient community.
Ann: Q2 2024 update, page-62
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |